KatherineTMurrayMD

Adult Congenital Heart Disease, Cardiac Electrophysiology

Professor, Medicine, Vanderbilt University School of Medicine

Dr. Murray is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Katherine Murray is a cardiologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center. She received her medical degree from Duke University School of Medicine and has been in practice 37 years. She specializes in atrial fibrillation and cardiac electrophysiology and is experienced in cardiac electrophysiology and icd / pacemaker insertion. She has more than 100 publications and over 500 citings.

Duke University HospitalFellowship, Clinical Cardiac Electrophysiology, 1986 - 1987
Duke University HospitalFellowship, Cardiovascular Disease, 1985 - 1986
Vanderbilt University Medical CenterFellowship, Clinical Pharmacology, 1983 - 1985
Vanderbilt University Medical CenterResidency, Internal Medicine, 1980 - 1983
Duke University School of MedicineClass of 1980

PubMed

1 citations
Incidence of Neuroleptic Malignant Syndrome During Antipsychotic Treatment in Children and Youth: A National Cohort Study.
Wayne A Ray, D Catherine Fuchs, Mark Olfson, Charles M Stein, Katherine T Murray
Journal of Child and Adolescent Psychopharmacology. 2024-11-01
2 citations
Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Soc...
Andreas Goette, Domenico Corradi, Dobromir Dobrev, Luis Aguinaga, Jose-Angel Cabrera
Europace. 2024-08-30
2 citations
LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation.
Matthew B Murphy, Zhenjiang Yang, Tuerdi Subati, Eric Farber-Eger, Kyungsoo Kim
Cardiovascular Research. 2024-07-02

J O U R N a L O F T H E a M E R I C a N C O L L E G E O F C a R D I O L O G Y v O L . 6 4 , N O . 2 1 , 2 0 1 4March 4th, 2019
VUMC Joins Research Network to Fight Atrial FibrillationJune 14th, 2018

Azithromycin And Sudden Cardiac Death: Electrophysiologic MechanismsNational Heart, Lung, And Blood Institute2012
Preamyloid Oligomers And Susceptibility To Atrial FibrillationNational Heart, Lung, And Blood Institute2010–2012
A Molecular Target For Atrial FibrillationNational Heart, Lung, And Blood Institute2003–2007
Molecular Targets In Atrial FibrillationNational Heart, Lung, And Blood Institute2002–2005
Molecular Modulation Of Cardiac Na+ Channel FunctionNational Heart, Lung, And Blood Institute2001–2004
Genetic Susceptibility In Acquired Long QT SyndromeNational Center For Research Resources1999–2002
Voltage Gated Cardiac Potassium ChannelsNational Heart, Lung, And Blood Institute1998–2001
Human Cardiac Na+ Channels--Effects Of PhosphorylationNational Heart, Lung, And Blood Institute1997–2000
Cellular Regulation Of Drug/Ion Channel InteractionsNational Heart, Lung, And Blood Institute1993–1996
Metabolic Regulation Of The Cardiac Sodium ChannelNational Heart, Lung, And Blood Institute1990–1994
Cellular Regulation Of Drug-Ion Channel InteractionsNational Heart, Lung, And Blood Institute1992